Literature DB >> 8197957

Hyperostosis in meningiomas: MR findings in patients with recurrent meningioma of the sphenoid wings.

K Terstegge1, W Schörner, H Henkes, N Heye, N Hosten, W R Lanksch.   

Abstract

PURPOSE: We used MR imaging to analyze retrospectively the pattern of hyperostosis occurring concomitantly with recurrent sphenoid wing meningiomas.
METHODS: Bone involvement was compared in 12 corresponding CT and MR studies of 10 female patients with sphenoid wing meningiomas recurrence after earlier surgical treatment. Four of these had histologically confirmed meningiomatous infiltration of the bone.
RESULTS: All patients had CT findings of localized hyperostosis of parts of the sphenoid wings. MR revealed inhomogeneous areas of slightly increased signal intensity in hyperostotic bone on T2-, proton density- and T1-weighted sequences. In nine of 10 patients, segments of the hyperostotic bone showed different degrees of gadolinium enhancement.
CONCLUSIONS: Because earlier studies have revealed high incidences of meningiomatous bone infiltration in sphenoid wing meningiomas, and because infiltration was confirmed in four of our patients, we postulate that the gadolinium enhancement in the area of hyperostosis may be related to meningiomatous bone infiltration.

Entities:  

Mesh:

Year:  1994        PMID: 8197957      PMCID: PMC8334301     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  2 in total

1.  Heterotopic ossification in psammomatous spinal meningioma: a diagnostic controversy.

Authors:  Yin Ping Wong; Geok Chin Tan; Shahizon Azura Mohamed Mukari; Kamalanathan Palaniandy
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

2.  Challenging the osseous component of sphenoorbital meningiomas.

Authors:  Svenja Maschke; Mauricio Martínez-Moreno; Alexander Micko; Matthias Millesi; Georgi Minchev; Ammar Mallouhi; Engelbert Knosp; Stefan Wolfsberger
Journal:  Acta Neurochir (Wien)       Date:  2019-08-01       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.